

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.57254825 |
| 2 | regulation of relaxation of muscle (GO:1901077) | 8.29194788 |
| 3 | myofibril assembly (GO:0030239) | 8.19311524 |
| 4 | sarcomere organization (GO:0045214) | 7.98696638 |
| 5 | actin filament-based movement (GO:0030048) | 7.91050699 |
| 6 | striated muscle contraction (GO:0006941) | 7.86049880 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.32620235 |
| 8 | creatine metabolic process (GO:0006600) | 6.97044045 |
| 9 | cardiac myofibril assembly (GO:0055003) | 6.85865678 |
| 10 | response to muscle activity (GO:0014850) | 6.83936162 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.75820007 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.64631371 |
| 13 | skeletal muscle fiber development (GO:0048741) | 6.47309230 |
| 14 | response to inactivity (GO:0014854) | 6.32468988 |
| 15 | cardiac muscle contraction (GO:0060048) | 6.22830131 |
| 16 | actomyosin structure organization (GO:0031032) | 5.95543280 |
| 17 | myotube cell development (GO:0014904) | 5.90340803 |
| 18 | muscle contraction (GO:0006936) | 5.88705364 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 5.73791429 |
| 20 | skeletal muscle adaptation (GO:0043501) | 5.59917858 |
| 21 | cardiac muscle hypertrophy (GO:0003300) | 5.38291292 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.29326874 |
| 23 | muscle system process (GO:0003012) | 5.26989324 |
| 24 | plasma membrane repair (GO:0001778) | 5.25323911 |
| 25 | glycogen catabolic process (GO:0005980) | 5.25253908 |
| 26 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.23754180 |
| 27 | striated muscle hypertrophy (GO:0014897) | 5.13204939 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 5.04140856 |
| 29 | muscle fiber development (GO:0048747) | 5.01370244 |
| 30 | NADH metabolic process (GO:0006734) | 4.95492696 |
| 31 | glucan catabolic process (GO:0009251) | 4.93929726 |
| 32 | skeletal muscle tissue development (GO:0007519) | 4.85403519 |
| 33 | glycogen biosynthetic process (GO:0005978) | 4.84919040 |
| 34 | glucan biosynthetic process (GO:0009250) | 4.84919040 |
| 35 | striated muscle adaptation (GO:0014888) | 4.71594545 |
| 36 | cellular polysaccharide catabolic process (GO:0044247) | 4.64916406 |
| 37 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.63963363 |
| 38 | muscle hypertrophy (GO:0014896) | 4.57469962 |
| 39 | muscle tissue morphogenesis (GO:0060415) | 4.47410205 |
| 40 | cardiac muscle cell development (GO:0055013) | 4.45627817 |
| 41 | adult heart development (GO:0007512) | 4.43228967 |
| 42 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.41444766 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 4.27502291 |
| 44 | regulation of the force of heart contraction (GO:0002026) | 4.26611377 |
| 45 | striated muscle cell development (GO:0055002) | 4.24799916 |
| 46 | muscle cell cellular homeostasis (GO:0046716) | 4.23454969 |
| 47 | skeletal muscle tissue regeneration (GO:0043403) | 4.21814701 |
| 48 | polysaccharide catabolic process (GO:0000272) | 4.18831022 |
| 49 | positive regulation of myotube differentiation (GO:0010831) | 4.17310688 |
| 50 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.15712765 |
| 51 | muscle cell fate commitment (GO:0042693) | 4.15005072 |
| 52 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.14303003 |
| 53 | cardiac cell development (GO:0055006) | 4.13749906 |
| 54 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.10044774 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 4.01771864 |
| 56 | fructose metabolic process (GO:0006000) | 3.97529619 |
| 57 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.94432177 |
| 58 | muscle organ development (GO:0007517) | 3.93687307 |
| 59 | muscle structure development (GO:0061061) | 3.93681302 |
| 60 | cardiac muscle adaptation (GO:0014887) | 3.85835393 |
| 61 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.85835393 |
| 62 | muscle hypertrophy in response to stress (GO:0003299) | 3.85835393 |
| 63 | glycogen metabolic process (GO:0005977) | 3.83051664 |
| 64 | muscle adaptation (GO:0043500) | 3.79304776 |
| 65 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.79069139 |
| 66 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.79069139 |
| 67 | glucan metabolic process (GO:0044042) | 3.75502377 |
| 68 | cellular glucan metabolic process (GO:0006073) | 3.75502377 |
| 69 | striated muscle atrophy (GO:0014891) | 3.70553620 |
| 70 | muscle organ morphogenesis (GO:0048644) | 3.70064698 |
| 71 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.68891040 |
| 72 | tricarboxylic acid cycle (GO:0006099) | 3.67592036 |
| 73 | carnitine shuttle (GO:0006853) | 3.66967425 |
| 74 | gluconeogenesis (GO:0006094) | 3.65593997 |
| 75 | muscle cell development (GO:0055001) | 3.64029398 |
| 76 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.58687688 |
| 77 | response to activity (GO:0014823) | 3.57616573 |
| 78 | myoblast fusion (GO:0007520) | 3.55527677 |
| 79 | regulation of myoblast differentiation (GO:0045661) | 3.54597729 |
| 80 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.53340571 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.53340571 |
| 82 | striated muscle tissue development (GO:0014706) | 3.43868277 |
| 83 | neuronal action potential propagation (GO:0019227) | 3.41929134 |
| 84 | positive regulation of cation channel activity (GO:2001259) | 3.39789989 |
| 85 | positive regulation of myoblast differentiation (GO:0045663) | 3.36246980 |
| 86 | regulation of muscle system process (GO:0090257) | 3.35460575 |
| 87 | relaxation of muscle (GO:0090075) | 3.34267487 |
| 88 | muscle atrophy (GO:0014889) | 3.31646134 |
| 89 | heart process (GO:0003015) | 3.31551334 |
| 90 | heart contraction (GO:0060047) | 3.31551334 |
| 91 | regulation of sarcomere organization (GO:0060297) | 3.28780872 |
| 92 | regulation of muscle contraction (GO:0006937) | 3.26578080 |
| 93 | hexose biosynthetic process (GO:0019319) | 3.25294875 |
| 94 | regulation of ATP catabolic process (GO:1903289) | 3.22848702 |
| 95 | regulation of ATPase activity (GO:0043462) | 3.22848702 |
| 96 | actin-myosin filament sliding (GO:0033275) | 12.9328549 |
| 97 | muscle filament sliding (GO:0030049) | 12.9328549 |
| 98 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.0740824 |
| 99 | actin-mediated cell contraction (GO:0070252) | 10.6508504 |
| 100 | skeletal muscle contraction (GO:0003009) | 10.0356475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.87089877 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.74866558 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.74075334 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.73034280 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.20159809 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.20159809 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.10248999 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.05518970 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.93258155 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.91865055 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.88765974 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.78255323 |
| 13 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.57427150 |
| 14 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.41511376 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28892082 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.17493228 |
| 17 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.14252133 |
| 18 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.96835032 |
| 19 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.87768157 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84120505 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77728487 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60474243 |
| 23 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.58441643 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57718103 |
| 25 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.53068033 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51307316 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.50124060 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47907722 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44095087 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41014416 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39059711 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33676458 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.31717465 |
| 34 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.30914822 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28649367 |
| 36 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25933877 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17367562 |
| 38 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.16069112 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16003122 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15424892 |
| 41 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.13480404 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12013022 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08464590 |
| 44 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.05354057 |
| 45 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03742395 |
| 46 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02392345 |
| 47 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01785851 |
| 48 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00217574 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00214558 |
| 50 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.99886117 |
| 51 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99811519 |
| 52 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99073985 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98339816 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97986961 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97583509 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97408272 |
| 57 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97337240 |
| 58 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.96006907 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95606186 |
| 60 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93260705 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91908639 |
| 62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91198410 |
| 63 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90945723 |
| 64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87687034 |
| 65 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87537349 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87091425 |
| 67 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.85359062 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.85302312 |
| 69 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85190703 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85067563 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83832085 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83832085 |
| 73 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83679387 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80978536 |
| 75 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79805055 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.79677546 |
| 77 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78769892 |
| 78 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.78726970 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77900442 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.77392647 |
| 81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76887413 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76632919 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76575598 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76222899 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76029138 |
| 86 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.75322591 |
| 87 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.74904904 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74163869 |
| 89 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.73913668 |
| 90 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.73635795 |
| 91 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.73610134 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.73037059 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72632581 |
| 94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.72365500 |
| 95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72329940 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71273284 |
| 97 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.70478373 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.69553221 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.69390281 |
| 100 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.69062403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.83174060 |
| 2 | MP0003646_muscle_fatigue | 6.75530871 |
| 3 | MP0000751_myopathy | 6.31874150 |
| 4 | MP0000749_muscle_degeneration | 5.70819233 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.59621704 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.80353330 |
| 7 | MP0004087_abnormal_muscle_fiber | 3.59500655 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.52759306 |
| 9 | MP0000747_muscle_weakness | 3.48924689 |
| 10 | MP0000759_abnormal_skeletal_muscle | 3.39723735 |
| 11 | MP0005451_abnormal_body_composition | 3.35647608 |
| 12 | MP0005369_muscle_phenotype | 3.19287623 |
| 13 | MP0000750_abnormal_muscle_regeneration | 3.00962574 |
| 14 | MP0002332_abnormal_exercise_endurance | 3.00532035 |
| 15 | MP0002269_muscular_atrophy | 2.98349653 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.97307696 |
| 17 | MP0005330_cardiomyopathy | 2.90142729 |
| 18 | MP0004130_abnormal_muscle_cell | 2.83518253 |
| 19 | MP0004233_abnormal_muscle_weight | 2.76512729 |
| 20 | MP0002972_abnormal_cardiac_muscle | 2.38908659 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.38141029 |
| 22 | MP0000733_abnormal_muscle_development | 2.17097804 |
| 23 | MP0004215_abnormal_myocardial_fiber | 2.07558398 |
| 24 | MP0002108_abnormal_muscle_morphology | 1.88452341 |
| 25 | MP0010630_abnormal_cardiac_muscle | 1.82769697 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.79150666 |
| 27 | MP0004484_altered_response_of | 1.75511797 |
| 28 | MP0002127_abnormal_cardiovascular_syste | 1.60548406 |
| 29 | MP0004510_myositis | 1.59229704 |
| 30 | MP0001544_abnormal_cardiovascular_syste | 1.51109521 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.51109521 |
| 32 | MP0004270_analgesia | 1.48609566 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.47239492 |
| 34 | MP0006138_congestive_heart_failure | 1.43079200 |
| 35 | MP0005266_abnormal_metabolism | 1.34530887 |
| 36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.33223440 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.28286116 |
| 38 | MP0003137_abnormal_impulse_conducting | 1.20400914 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.14557677 |
| 40 | MP0001661_extended_life_span | 1.08123920 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.06890793 |
| 42 | MP0002971_abnormal_brown_adipose | 1.03810900 |
| 43 | MP0004085_abnormal_heartbeat | 0.91995265 |
| 44 | MP0005666_abnormal_adipose_tissue | 0.90139696 |
| 45 | MP0002822_catalepsy | 0.88391406 |
| 46 | MP0003828_pulmonary_edema | 0.84461578 |
| 47 | MP0005375_adipose_tissue_phenotype | 0.84428834 |
| 48 | MP0005670_abnormal_white_adipose | 0.82381342 |
| 49 | MP0004147_increased_porphyrin_level | 0.76835937 |
| 50 | MP0000003_abnormal_adipose_tissue | 0.76244425 |
| 51 | MP0003045_fibrosis | 0.72864601 |
| 52 | MP0000266_abnormal_heart_morphology | 0.69793034 |
| 53 | MP0000372_irregular_coat_pigmentation | 0.59907138 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 0.56263762 |
| 55 | MP0004134_abnormal_chest_morphology | 0.54645097 |
| 56 | MP0001299_abnormal_eye_distance/ | 0.53732438 |
| 57 | MP0003879_abnormal_hair_cell | 0.52278172 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 0.52249404 |
| 59 | MP0004043_abnormal_pH_regulation | 0.47902968 |
| 60 | MP0002128_abnormal_blood_circulation | 0.45115264 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.43616604 |
| 62 | MP0008569_lethality_at_weaning | 0.41182192 |
| 63 | MP0005083_abnormal_biliary_tract | 0.38733609 |
| 64 | MP0002638_abnormal_pupillary_reflex | 0.38347452 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 0.38324940 |
| 66 | MP0009672_abnormal_birth_weight | 0.37209189 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.36886787 |
| 68 | MP0005165_increased_susceptibility_to | 0.36522756 |
| 69 | MP0010030_abnormal_orbit_morphology | 0.36259237 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.35399983 |
| 71 | MP0004142_abnormal_muscle_tone | 0.35306872 |
| 72 | MP0000762_abnormal_tongue_morphology | 0.35082443 |
| 73 | MP0002114_abnormal_axial_skeleton | 0.31219239 |
| 74 | MP0002734_abnormal_mechanical_nocicepti | 0.30706079 |
| 75 | MP0005166_decreased_susceptibility_to | 0.29998725 |
| 76 | MP0003948_abnormal_gas_homeostasis | 0.29990733 |
| 77 | MP0005452_abnormal_adipose_tissue | 0.29668570 |
| 78 | MP0000230_abnormal_systemic_arterial | 0.29042799 |
| 79 | MP0009250_abnormal_appendicular_skeleto | 0.28929139 |
| 80 | MP0005535_abnormal_body_temperature | 0.28331948 |
| 81 | MP0001346_abnormal_lacrimal_gland | 0.26591353 |
| 82 | MP0005187_abnormal_penis_morphology | 0.26373067 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 0.26298330 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.26172374 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.25688208 |
| 86 | MP0003941_abnormal_skin_development | 0.24841288 |
| 87 | MP0004858_abnormal_nervous_system | 0.22899789 |
| 88 | MP0005332_abnormal_amino_acid | 0.22033553 |
| 89 | MP0005334_abnormal_fat_pad | 0.20746915 |
| 90 | MP0001943_abnormal_respiration | 0.20581455 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.20026097 |
| 92 | MP0005423_abnormal_somatic_nervous | 0.19837381 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 0.19624084 |
| 94 | MP0002234_abnormal_pharynx_morphology | 0.17940624 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 0.16642505 |
| 96 | MP0004924_abnormal_behavior | 0.15063255 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.15063255 |
| 98 | MP0001529_abnormal_vocalization | 0.15037152 |
| 99 | MP0008874_decreased_physiological_sensi | 0.14670799 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.14552705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 8.37030068 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.92717190 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.35456844 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.43950863 |
| 5 | Distal arthrogryposis (HP:0005684) | 5.74994350 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.70859375 |
| 7 | Myopathic facies (HP:0002058) | 5.63846297 |
| 8 | EMG: myopathic abnormalities (HP:0003458) | 5.36706946 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.11388808 |
| 10 | Round ear (HP:0100830) | 4.80110417 |
| 11 | Rhabdomyolysis (HP:0003201) | 4.80092647 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 4.79466076 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 4.77378629 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.70486364 |
| 15 | Myoglobinuria (HP:0002913) | 4.70151801 |
| 16 | Ulnar deviation of the wrist (HP:0003049) | 4.51587440 |
| 17 | Subaortic stenosis (HP:0001682) | 4.48987259 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.48987259 |
| 19 | Neck muscle weakness (HP:0000467) | 4.44406113 |
| 20 | Rimmed vacuoles (HP:0003805) | 4.34863218 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.24487498 |
| 22 | Difficulty running (HP:0009046) | 4.00387056 |
| 23 | Calcaneovalgus deformity (HP:0001848) | 3.93835244 |
| 24 | Distal lower limb muscle weakness (HP:0009053) | 3.79348037 |
| 25 | Increased connective tissue (HP:0009025) | 3.79075608 |
| 26 | Muscle stiffness (HP:0003552) | 3.78414681 |
| 27 | Sudden death (HP:0001699) | 3.76358099 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.59405654 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.55818882 |
| 30 | Absent phalangeal crease (HP:0006109) | 3.55780739 |
| 31 | Deformed tarsal bones (HP:0008119) | 3.49233942 |
| 32 | Myotonia (HP:0002486) | 3.48820679 |
| 33 | Areflexia of lower limbs (HP:0002522) | 3.38686723 |
| 34 | Bundle branch block (HP:0011710) | 3.37335607 |
| 35 | Malignant hyperthermia (HP:0002047) | 3.33030533 |
| 36 | Frequent falls (HP:0002359) | 3.30662163 |
| 37 | EMG: neuropathic changes (HP:0003445) | 3.16298608 |
| 38 | Ventricular tachycardia (HP:0004756) | 3.03091028 |
| 39 | Generalized muscle weakness (HP:0003324) | 2.97831019 |
| 40 | Abnormal finger flexion creases (HP:0006143) | 2.95089445 |
| 41 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.91890146 |
| 42 | Distal lower limb amyotrophy (HP:0008944) | 2.79372062 |
| 43 | Dilated cardiomyopathy (HP:0001644) | 2.72413556 |
| 44 | Fetal akinesia sequence (HP:0001989) | 2.69078177 |
| 45 | Lipoatrophy (HP:0100578) | 2.53405190 |
| 46 | Bulbar palsy (HP:0001283) | 2.51503934 |
| 47 | Weak cry (HP:0001612) | 2.47361177 |
| 48 | Abnormality of the neuromuscular junction (HP:0003398) | 2.46283935 |
| 49 | Fatigable weakness (HP:0003473) | 2.46283935 |
| 50 | Slender build (HP:0001533) | 2.42171470 |
| 51 | Gowers sign (HP:0003391) | 2.41795056 |
| 52 | Progressive muscle weakness (HP:0003323) | 2.37753055 |
| 53 | Scapular winging (HP:0003691) | 2.33047118 |
| 54 | Limb-girdle muscle atrophy (HP:0003797) | 2.31776751 |
| 55 | Hip contracture (HP:0003273) | 2.31761363 |
| 56 | Hyperkalemia (HP:0002153) | 2.29344299 |
| 57 | Difficulty climbing stairs (HP:0003551) | 2.29088618 |
| 58 | Abnormality of the calcaneus (HP:0008364) | 2.27925118 |
| 59 | Muscular dystrophy (HP:0003560) | 2.17807377 |
| 60 | Spinal rigidity (HP:0003306) | 2.16615051 |
| 61 | Heart block (HP:0012722) | 2.15980505 |
| 62 | Lower limb amyotrophy (HP:0007210) | 2.12585476 |
| 63 | Waddling gait (HP:0002515) | 2.08157003 |
| 64 | Abnormality of the foot musculature (HP:0001436) | 2.05900288 |
| 65 | Proximal amyotrophy (HP:0007126) | 2.05704945 |
| 66 | Abnormal atrioventricular conduction (HP:0005150) | 2.03615282 |
| 67 | Nemaline bodies (HP:0003798) | 11.0259277 |
| 68 | Muscle fiber inclusion bodies (HP:0100299) | 11.0165557 |
| 69 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.8114237 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 1.94412685 |
| 71 | Popliteal pterygium (HP:0009756) | 1.92329631 |
| 72 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.91409230 |
| 73 | Ventricular arrhythmia (HP:0004308) | 1.86844451 |
| 74 | Foot dorsiflexor weakness (HP:0009027) | 1.84701401 |
| 75 | Long clavicles (HP:0000890) | 1.82760792 |
| 76 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.81426697 |
| 77 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.79229500 |
| 78 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.79229500 |
| 79 | Exercise intolerance (HP:0003546) | 1.77740001 |
| 80 | Shoulder girdle muscle weakness (HP:0003547) | 1.75171031 |
| 81 | Pelvic girdle muscle weakness (HP:0003749) | 1.74911433 |
| 82 | Limb-girdle muscle weakness (HP:0003325) | 1.70938623 |
| 83 | Facial diplegia (HP:0001349) | 1.70587231 |
| 84 | Paralysis (HP:0003470) | 1.70022211 |
| 85 | Type 2 muscle fiber atrophy (HP:0003554) | 1.68675656 |
| 86 | Nonprogressive disorder (HP:0003680) | 1.68628220 |
| 87 | Metatarsus adductus (HP:0001840) | 1.57062833 |
| 88 | Limited hip movement (HP:0008800) | 1.55892369 |
| 89 | Muscle fiber atrophy (HP:0100295) | 1.55624416 |
| 90 | Increased intramyocellular lipid droplets (HP:0012240) | 1.55041359 |
| 91 | Atrial fibrillation (HP:0005110) | 1.53792211 |
| 92 | Ulnar deviation of finger (HP:0009465) | 1.47606264 |
| 93 | Increased muscle lipid content (HP:0009058) | 1.44779077 |
| 94 | Steppage gait (HP:0003376) | 1.40242259 |
| 95 | Primary atrial arrhythmia (HP:0001692) | 1.39030245 |
| 96 | Abnormality of placental membranes (HP:0011409) | 1.38503211 |
| 97 | Amniotic constriction ring (HP:0009775) | 1.38503211 |
| 98 | Supraventricular tachycardia (HP:0004755) | 1.34688486 |
| 99 | Oligomenorrhea (HP:0000876) | 1.32684892 |
| 100 | Left ventricular hypertrophy (HP:0001712) | 1.31299514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.50629576 |
| 2 | PHKG1 | 6.04931035 |
| 3 | PHKG2 | 6.04931035 |
| 4 | PIK3CG | 2.90588986 |
| 5 | MAPK12 | 2.00995417 |
| 6 | OBSCN | 10.6869687 |
| 7 | MUSK | 1.91943798 |
| 8 | MAP2K3 | 1.83345655 |
| 9 | PINK1 | 1.76060570 |
| 10 | MAP3K7 | 1.67827503 |
| 11 | MAPKAPK3 | 1.57744236 |
| 12 | NME1 | 1.20700720 |
| 13 | MAP2K4 | 1.15811687 |
| 14 | TRPM7 | 1.11074188 |
| 15 | DMPK | 1.10795029 |
| 16 | MARK1 | 1.07986870 |
| 17 | MOS | 1.07328608 |
| 18 | LIMK1 | 1.04433020 |
| 19 | NEK1 | 0.99341690 |
| 20 | EEF2K | 0.95414884 |
| 21 | CAMK2G | 0.92206105 |
| 22 | CCNB1 | 0.87898021 |
| 23 | MAP2K6 | 0.87536644 |
| 24 | PRKAA2 | 0.78958311 |
| 25 | NEK9 | 0.74472026 |
| 26 | MAP3K13 | 0.71766062 |
| 27 | PRKAA1 | 0.70357365 |
| 28 | DYRK1B | 0.70154334 |
| 29 | CAMK4 | 0.69524262 |
| 30 | ERBB3 | 0.67174534 |
| 31 | PIK3CA | 0.66543794 |
| 32 | PDK2 | 0.66138514 |
| 33 | MAPK7 | 0.61829242 |
| 34 | AKT2 | 0.61537380 |
| 35 | RIPK1 | 0.59051269 |
| 36 | BCKDK | 0.58340940 |
| 37 | CAMK2D | 0.57675626 |
| 38 | TRIB3 | 0.57290799 |
| 39 | CAMK1 | 0.57235314 |
| 40 | PRKG1 | 0.51913816 |
| 41 | PKN1 | 0.50950752 |
| 42 | MAPK11 | 0.50911447 |
| 43 | MAP2K1 | 0.50897767 |
| 44 | KSR2 | 0.49271611 |
| 45 | MAPK4 | 0.48986479 |
| 46 | CAMK2A | 0.48464866 |
| 47 | ROCK1 | 0.47180617 |
| 48 | CAMK2B | 0.45592753 |
| 49 | SGK3 | 0.40824448 |
| 50 | LATS2 | 0.36406624 |
| 51 | ICK | 0.34986510 |
| 52 | PRKACA | 0.32071608 |
| 53 | RPS6KB2 | 0.32031706 |
| 54 | TIE1 | 0.32023125 |
| 55 | GRK7 | 0.29888702 |
| 56 | TBK1 | 0.28622273 |
| 57 | SGK2 | 0.27552300 |
| 58 | RPS6KA3 | 0.26688446 |
| 59 | RPS6KB1 | 0.23166582 |
| 60 | MAP3K1 | 0.22996753 |
| 61 | SGK1 | 0.22938850 |
| 62 | MAPK10 | 0.22733293 |
| 63 | PRKACB | 0.22644647 |
| 64 | PRKD1 | 0.22518447 |
| 65 | ARAF | 0.20567281 |
| 66 | TAOK2 | 0.20552602 |
| 67 | MAPK13 | 0.19666012 |
| 68 | MARK2 | 0.19484510 |
| 69 | EPHB1 | 0.19285946 |
| 70 | SIK1 | 0.18312235 |
| 71 | MYLK | 0.18186619 |
| 72 | PRPF4B | 0.16650501 |
| 73 | RPS6KA1 | 0.16075315 |
| 74 | RPS6KC1 | 0.15489196 |
| 75 | RPS6KL1 | 0.15489196 |
| 76 | PRKACG | 0.15073940 |
| 77 | PDPK1 | 0.15070627 |
| 78 | MAP3K10 | 0.14687030 |
| 79 | DAPK2 | 0.14279401 |
| 80 | MAP3K11 | 0.13836233 |
| 81 | RAF1 | 0.13212448 |
| 82 | MTOR | 0.12403265 |
| 83 | PTK2B | 0.11835453 |
| 84 | RPS6KA6 | 0.11517946 |
| 85 | SGK223 | 0.10550623 |
| 86 | SGK494 | 0.10550623 |
| 87 | STK11 | 0.10496726 |
| 88 | CDC42BPA | 0.10338847 |
| 89 | PDK1 | 0.10152934 |
| 90 | LATS1 | 0.10061837 |
| 91 | MAP3K6 | 0.08925463 |
| 92 | ZAP70 | 0.08559173 |
| 93 | MARK3 | 0.08186243 |
| 94 | MAP3K5 | 0.08002854 |
| 95 | KSR1 | 0.07693568 |
| 96 | MAP3K3 | 0.06933898 |
| 97 | EPHA3 | 0.06120077 |
| 98 | MAP3K9 | 0.05806028 |
| 99 | BRAF | 0.04705840 |
| 100 | CDK19 | 0.04507798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.80075752 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.58068260 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.35933102 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.01488422 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.94153083 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.43262727 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.39192879 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.52043967 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.39642738 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.15452909 |
| 11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.15401617 |
| 12 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.99785095 |
| 13 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.94568878 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.92889932 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80967324 |
| 16 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.79502963 |
| 17 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.76861991 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.68134308 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65843944 |
| 20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.60271181 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.57286140 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.53820480 |
| 23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.52006679 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.50929777 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50288727 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49238581 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43355906 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.31250157 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.24331430 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21644737 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20632617 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18901399 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.18391012 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12237857 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11268688 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03198442 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02323732 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01208006 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99054476 |
| 40 | Tight junction_Homo sapiens_hsa04530 | 0.96714400 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96673312 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91417841 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89230021 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.83101746 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82585061 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.80562104 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77008457 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75524200 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.73089383 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69961686 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67884108 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64612244 |
| 53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64328780 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 0.61381102 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53508642 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50100092 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49935949 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49131718 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45559199 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45125766 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44621836 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44169226 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.42963763 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41740136 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41032175 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39780276 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34590260 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34342374 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.34249171 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32178817 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31605902 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.31599966 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31182137 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.30836145 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28353249 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.26192655 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.24200405 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23333121 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22923509 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.22872113 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22635896 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22035163 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21721674 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21039842 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20611847 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20239186 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18856553 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18815929 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.18526865 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17557574 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.16160370 |
| 92 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15673144 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.14970614 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.14950686 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.13642370 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.11575320 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.11363960 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.09834270 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.08012025 |
| 100 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.07323093 |

